Adoptive Immunotherapy for Malignant Brain Tumors Using Killer T Lymphocytes Enhanced by Interferon Gamma Gene Transfer

使用干扰素 γ 基因转移增强的杀伤性 T 淋巴细胞对恶性脑肿瘤进行过继免疫治疗

基本信息

项目摘要

A mouse ihterfebon (IFN) gamma CDNA was transferred to mouse neuroblastoma cell line, C1300 of A/Jax origin, with a chimeric retrovirus containing the IFN gamma gene. Two infected subclones C-gamma-3 and C-gamma-22 were obtained as a low and a high producers, respectively. These subclones were similar to the original clone in respects of in vitro growth pattern, morphology, and antigen expression of neurofilaments, except the expression of major hisiocompatibility complex (MHC) class I antigens, which were extremely augmented at the surface expression level as well as at the transcription level, regardless the difference in amount of their IFN-gamma production. The in vivo tumorigenicity was reduced in the high producer, C-gamma-22, but not in the low producer, C-gamma-3. The in vivo tumor growth rate was suppressed in both subclones, as compared to the parental line. It was therefore suggested that the suppression of tumor formation is more closely associated with constitutive IFN-gam … More ma production rather than the MHC antigen expression, and that the tumor growth rate is affected by the high expression of the surface antigens.As a next step, the cDNA encoding mouse IFN-gamma was transferred into a specific cytotoxic T lymphocyte (CTL) clone, designated E-4, against 203-glioma (a 20- methylcholanthrene-induced glioma line of C57/BL mouse origin). The efficacy of IFN-gamma production from the exogenous gene on augumeniation of tumor targeting was confirmed. Out of five, two gene-transferred subclones constitutively produced 8 to 10 times higher amount of IFN-gamma as compared with the parental E-4. Correspondingly, these two subclones exhibited 2 to 3 times higher killing activity against 203-glioma as compared with the parental line. It was thought that tumor cells, in the vicinity of the constitutively IFN-gamma-producing CTLs, may be stimulated to induce or enhance the expression of surface antigens, including the MHC antigens as well as the tumor associated antigens relevant to immune recognition.In summary, it was hopefully suggested that retrovirus-mediated transfer of cytokine genes would be useful for a modified immunotherapy of cancer. Less
用含有IFN γ基因的嵌合逆转录病毒将小鼠IFN γ cDNA转移到A/Jax来源的小鼠神经母细胞瘤细胞系C1300中。获得了两个感染的亚克隆C-gamma-3和C-gamma-22,分别作为低生产者和高生产者。这些亚克隆在体外生长模式、形态和神经丝的抗原表达方面与原始克隆相似,除了主要组织相容性复合物(MHC)I类抗原的表达,其在表面表达水平以及转录水平上极大地增强,而不管它们的IFN-γ产生量的差异。体内致瘤性在高生产者C-γ-22中降低,但在低生产者C-γ-3中不降低。与亲本细胞系相比,两个亚克隆的体内肿瘤生长速率均受到抑制。因此,提示肿瘤形成的抑制与组成性IFN-γ更密切相关。 ...更多信息 作为下一步,将编码小鼠IFN-γ的cDNA转移到特异性细胞毒性T淋巴细胞(CTL)克隆中,命名为E-4,其针对203-胶质瘤(C57/BL小鼠来源的20-甲基胆蒽诱导的胶质瘤系)。从外源基因产生IFN-γ对增强肿瘤靶向的功效得到证实。在五个中,两个基因转移的亚克隆组成性地产生与亲本E-4相比高8至10倍的IFN-γ量。相应地,这两个亚克隆对203-胶质瘤的杀伤活性比亲本系高2至3倍。人们认为,在组成性产生IFN-γ的CTL附近的肿瘤细胞可以被刺激以诱导或增强表面抗原的表达,包括MHC抗原以及与免疫识别相关的肿瘤相关抗原。少

项目成果

期刊论文数量(71)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Yamashita J,Handa H: "Diagnosis and treatment of pineal tumours.Kyoto University experience(1941-1984)" Acta Neurochirur. 42. 137-141 (1988)
Yamashita J,Handa H:“松果体肿瘤的诊断和治疗。京都大学经验(1941-1984)”Acta Neurochirur。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
山下純宏,石川正恒,菊池晴彦(分担執筆): "PET「図解臨床癌シリ-ズNo.15脳腫瘍」" メジカルビュ-社, (1987)
山下淳弘、石川正恒、菊池晴彦(合着):《PET“临床癌症图解系列第 15 期脑肿瘤》,Medical View-sha,(1987 年)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
山下純宏: "informixによるデ-タベ-ス管理,脳腫瘍患者管理デ-タベ-スの紹介" 月刊メディカルパソコン. 2. 137-148 (1987)
Sumihiro Yamashita:“使用 informix 进行数据库管理,脑肿瘤患者管理数据库介绍”《医学计算机月刊》2. 137-148 (1987)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
山下純宏: "Phacamatosisの画像診断" Clin Neurosci. 5. 1028-1031 (1987)
Sumihiro Yamashita:“斑疹伤寒的影像诊断”《临床神经科学》5. 1028-1031 (1987)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
石田陽一,影山直樹,高倉公明,吉田純,河本圭司,山下純宏(共編): "「脳腫瘍病理カラ-アトラス」" 医学書院, (1987)
Yoichi Ishida、Naoki Kageyama、Kimiaki Takakura、Jun Yoshida、Keiji Kawamoto、Sumihiro Yamashita(共同编辑):“‘脑肿瘤病理学彩色图谱’”Igaku Shoin,(1987)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMASHITA Junkoh其他文献

YAMASHITA Junkoh的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMASHITA Junkoh', 18)}}的其他基金

The analysis of transcription factor and ECM degradation enzyme associated with invasion of glioblastoma
胶质母细胞瘤侵袭相关转录因子及ECM降解酶分析
  • 批准号:
    13470290
  • 财政年份:
    2001
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The analysis of invasion associated gene in glioblastoma
胶质母细胞瘤侵袭相关基因分析
  • 批准号:
    11470286
  • 财政年份:
    1999
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
Analysis of cell death inducing gene in human malignant gliomas
人恶性胶质瘤细胞死亡诱导基因分析
  • 批准号:
    09470292
  • 财政年份:
    1997
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Inhibition of Gene Expression from the Human c-erb B Gene Promoter by a Retroviral Vector Expressing Anti-gene RNA
表达反基因 RNA 的逆转录病毒载体抑制人 c-erb B 基因启动子的基因表达
  • 批准号:
    07457310
  • 财政年份:
    1995
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of chemokine-expressing retrovirus vector system in malignant gliomas
恶性胶质瘤表达趋化因子的逆转录病毒载体系统的开发
  • 批准号:
    07557359
  • 财政年份:
    1995
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
INHIBITION OF TRANSCRIPTION OF THE HUMAN EGFR GENE IN GLIOMA BY SITE-SPECIFIC OLIGONUCLEOTIDES DESIGNED TO FORM DNA TRIPLE HELICES
通过旨在形成 DNA 三螺旋的位点特异性寡核苷酸抑制神经胶质瘤中人类 EGFR 基因的转录
  • 批准号:
    05454395
  • 财政年份:
    1993
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

NSF PRFB FY23: Understanding the evolutionary importance and vectoring mechanisms of horizontal gene transfer within a parasitic plant system
NSF PRFB FY23:了解寄生植物系统内水平基因转移的进化重要性和矢量机制
  • 批准号:
    2305877
  • 财政年份:
    2024
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Fellowship Award
Horizontal gene transfer of cyanobacterial carbon fixing machinery: Implications for the rise of modern atmospheric oxygen
蓝藻固碳机制的水平基因转移:对现代大气氧气上升的影响
  • 批准号:
    NE/Z00019X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Research Grant
CAREER: Elucidating trans-kingdom horizontal gene transfer mechanisms to improve plant genetic engineering
职业:阐明跨界水平基因转移机制以改进植物基因工程
  • 批准号:
    2340175
  • 财政年份:
    2024
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Continuing Grant
ELAVL1 role in glioblastoma heterogeneity through intercellular gene transfer mediated by cell fusion and tunneling membrane nanotube formation
ELAVL1通过细胞融合和隧道膜纳米管形成介导的细胞间基因转移在胶质母细胞瘤异质性中的作用
  • 批准号:
    10658226
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Mechanism of immune response to muscle-directed AAV gene transfer
肌肉定向 AAV 基因转移的免疫反应机制
  • 批准号:
    10717750
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
CAREER: Harnessing horizontal gene transfer to engineer environmental microbiomes in situ
职业:利用水平基因转移原位改造环境微生物组
  • 批准号:
    2237052
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Continuing Grant
Mechanisms and regulation of replication, the cell cycle, gene expression, and horizontal gene transfer in prokaryotes, focusing on Bacillus subtilis
原核生物复制、细胞周期、基因表达和水平基因转移的机制和调控,重点关注枯草芽孢杆菌
  • 批准号:
    10792219
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Carbon Nanotube-Mediated Gene Transfer into Human T-cells for CAR-T HIV Therapy
碳纳米管介导的基因转移到人类 T 细胞中用于 CAR-T HIV 治疗
  • 批准号:
    10601451
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Novel bioreducible polymer-based delivery platform for intravitreal gene transfer to retina
用于玻璃体内基因转移至视网膜的新型生物可还原聚合物递送平台
  • 批准号:
    10573812
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
Removal of antibiotic resistant bacteria and antibiotic resistant gene during ozonation, and quantitative evaluation of horizontal gene transfer
臭氧氧化过程中抗生素耐药菌和抗生素耐药基因的去除以及水平基因转移的定量评估
  • 批准号:
    23K17053
  • 财政年份:
    2023
  • 资助金额:
    $ 3.9万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了